Morgan Lewis is sponsoring the U.S.-China Pharma conference.
This conference focuses on opportunities in licensing in the China market, including best practices and strategies in leveraging partnerships, alliances, collaborations, outsourcing, and in-licensing to improve productivity and contain costs in R&D projects. It is targeted to vice presidents, directors and managers of pharmaceutical, biotech and life science companies.
At the conference, Morgan Lewis associate Wenseng "Wendy" Pan will participate in a panel discussion of "Emerging Licensing Opportunities in China." This discussion will cover:
May 23–24, 2011
Hub Cira Centre